PACB
PACB
US69404D1081
Pacific Biosciences of Californ
Loading chart...

Valuation & History

Quarterly trend of key valuation metrics

Metric
Current (TTM) TTM Baseline
Q2 '26 30.06.2026
Q1 '26 31.03.2026
Q4 '25 31.12.2025
Market & Enterprise Value
Market Cap
724.24M EUR
522.16M EUR
409.84M EUR
564.66M EUR
Enterprise Value
1.19B EUR
1.17B EUR
1.06B EUR
1.2B EUR
Valuation Multiples
Trailing P/E
--
--
--
--
Forward P/E
-5.53x
--
--
--
Price to Sales
4.55x
3.28x
2.56x
4.6x
Price to Book
--
--
173.22x
105.56x
EV/Revenue
7.45x
7.33x
6.6x
9.8x
EV/EBITDA
5.96x
--
--
--
Price to FCF (P/FCF)
2.48x
--
--
--
EV/FCF
4.07x
--
--
--
FCF Yield
40.27%
-24.99%
-29.58%
-12.13%
ende